Physician profile
Mark S Wathen
NPI 1104925536
$4,610.42
in general payments reported to CMS, 2019-2025
15 companies · $710 in 2025
The $710 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $69.86 · 2021: $200 · 2022: $62.45 · 2023: $2,339 · 2024: $244 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278 · Travel and Lodging: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.06 |
| Travel and Lodging | $1,014.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,816.47 | 2021-2025 | Micra, Tyrx |
| Boston Scientific Corporation | $643.39 | 2019-2025 | Farapulse, Watchman Flx, General - Structural Heart |
| Medtronic Vascular, INC. | $610.56 | 2019-2020 | |
| Biosense Webster, INC. | $427.19 | 2025 | Carto 3 |
| Biotronik INC. | $333.39 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Altathera Pharmaceuticals LLC | $313.10 | 2023 | Sotalol Hydrochloride |
| Cvrx, INC. | $207.45 | 2023-2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $87.30 | 2023-2024 | |
| Pfizer INC. | $43.64 | 2022-2023 | |
| Baxter Healthcare | $33.27 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Esperion Therapeutics, INC. | $23.31 | 2020 | |
| Amgen INC. | $20.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.56 | 2021 | |
| Abbott Laboratories | $17.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wathen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.